Clinical Trials
3 trialsNCT04247984 2022-03-11
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
ChineseAMS
Phase 2 Completed
NCT01529164 2013-11-27
Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer
ChineseAMS
Phase 2 Unknown
NCT01679327 2012-09-06
Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
ChineseAMS
Phase 2 Unknown